text
"['\n4. 매출 및 수주상황\n가. 매출실적\n(단위 :천원 \xa0)\n사업부문\n매출유형\n품 목\n\xa0제63기분기\n\xa0제62기연간\n\xa0제61기연간\n의약품제조\n제품\n케펜텍\n수출\n7,653,222\n8,673,228\n9,660,752\n내수\n5,142,606\n7,081,553\n7,237,226\n합계\n12,795,828\n15,754,781\n16,897,978\n쿨파프\n수출\n240,659\n-\n747,534\n내수\n2,166,322\n2,003,977\n2,435,728\n합계\n2,406,981\n2,003,977\n3,183,262\n리피토플러스\n내수\n6,424,567\n3,359,900\n-\n넥실렌\n내수\n5,951,967\n10,197,180\n11,483,950\n란스톤캡슐\n내수\n5,589,821\n6,650,092\n7,746,055\n필그렐정\n내수\n5,152,811\n6,150,724\n5,886,600\n클로피린캡슐\n내수\n5,098,151\n6,564,365\n6,153,121\n베라실\n내수\n4,397,215\n5,817,961\n5,736,313\n비유피-4\n내수\n4,392,577\n6,245,158\n6,154,792\n티에스원\n내수\n3,791,512\n5,454,509\n6,176,373\n크라비트주\n수출\n138,490\n183,682\n355,311\n내수\n3,649,634\n4,321,967\n5,452,808\n합계\n3,788,124\n4,505,649\n5,808,119\n스타브론\n내수\n3,778,158\n5,968,898\n5,962,636\n기타\n수출\n19,582,705\n21,779,785\n29,433,353\n내수\n46,333,545\n57,466,909\n63,953,972\n합계\n65,916,250\n79,246,694\n93,387,325\n소계\n수출\n27,615,076\n30,636,695\n40,196,950\n내수\n101,868,886\n127,283,193\n134,379,574\n합계\n129,483,962\n157,919,888\n174,576,524\n상품\n리피토\n내수\n136,601,140\n176,606,941\n168,564,373\n리리카\n내수\n53,856,834\n66,982,277\n64,726,691\n쎄레브렉스\n내수\n36,127,531\n47,318,842\n45,683,278\n네시나\n내수\n23,383,224\n32,329,548\n33,011,509\n뉴론틴\n내수\n18,017,874\n23,741,407\n22,399,534\n란스톤엘에프디티\n내수\n17,929,276\n29,921,078\n31,464,776\n덱실란트디알캡슐\n내수\n16,030,886\n17,528,588\n18,212,618\n액토스정\n내수\n15,051,211\n21,723,180\n21,740,264\n카듀엣\n내수\n13,993,586\n18,484,886\n18,940,655\n니슬 링클더마 필름\n수출\n10,846\n8,044\n168,595\n내수\n691,108\n3,003,392\n9,124,095\n합계\n701,954\n3,011,436\n9,292,690\n한방파프수\n내수\n2,339,189\n2,934,782\n2,918,821\n록펜텍\n내수\n979,420\n1,309,579\n1,415,110\n기타\n수출\n26,885\n356,904\n1,494,411\n내수\n131,264,866\n152,432,522\n135,661,559\n합계\n131,291,751\n152,789,426\n137,155,970\n소계\n수출\n37,731\n364,948\n1,663,006\n내수\n466,266,145\n594,317,022\n573,863,283\n합계\n466,303,876\n594,681,970\n575,526,289\n기타\n수탁매출외\n내수\n2,244,968\n3,725,307\n3,454,186\n지주사외\n기타\n경영자문\n내수\n2,812,524\n3,660,158\n4,288,099\n임대료\n내수\n3,598,663\n4,929,904\n6,097,422\n지분법수익\n내수\n2,527,940\n3,328,312\n6,645,185\n판매대행\n내수\n17,316,773\n23,211,328\n20,662,001\n합 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0계\n수출\n27,652,807\n31,001,643\n41,859,956\n내수\n596,635,899\n760,455,224\n749,389,750\n합계\n624,288,706\n791,456,867\n791,249,706\n* 위 매출현황은 내부거래 제거전 매출현황임(제일약품은 연결기준 매출액 반영)나. 판매경로 및 판매방법 등\n(1) 판매경로\n\xa0[제일약품] \xa0 \xa0 원외 \xa0 \xa0 \xa0 : \xa0 85.4% \xa0 \xa0 \xa0 종합병원 : \xa0 \xa07.9% \xa0 \xa0 \xa0 \xa0 \xa0관계사 \xa0 \xa0: \xa0 \xa0 0.8%  \xa0 \xa0 기타 \xa0 \xa0 \xa0 : \xa0 \xa02.6% \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0 \xa0 : \xa0 \xa03.3% [제일헬스사이언스] \xa0 약국 \xa0 \xa0: \xa0 58.6% \xa0 \xa0 \xa0 \xa0 \xa0 도매 \xa0 \xa0: \xa0 11.6% \xa0 \xa0 \xa0 \xa0 \xa0특판 \xa0 \xa0: \xa0 \xa06.4%  \xa0기타 \xa0 \xa0: \xa0 \xa0 6.2% \xa0 \xa0 \xa0 \xa0 \xa0 수출 \xa0 \xa0: \xa0 \xa017.2%\n(2) 판매방법 및 조건\n\xa0 방법 : 주문판매 \xa0조건 : 외상매출후 현금, 어음, 카드등 수금\n']"
